Reinforced adversarial neural model for drug discovery and longevity biotechnology industry

(InSilico Medicine, Inc.) Insilico introduces RANC architecture for de novo molecular design. The engine generates more unique and diverse structures as well as clusters with the lengths close to the reference samples, keeping the distributions of key molecular descriptors as in the training sets.